Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.41 |
| ▸ | CDK4 | P11802 | 1/20 | 0.41 |
| ▸ | CCND1 | P24385 | 1/20 | 0.41 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.41 |
| ▸ | CDK2 | P24941 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | SPHK2 | Q9NRA0 | 5/20 | 0.39 |
| ▸ | SPHK1 | Q9NYA1 | 4/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7839730 | 1.00 | MEN1 (0.46) | MEN1KMT2ACCNE2CDK4CCND1 | |
| SCHEMBL18040352 | 0.95 | CYP2D6 (0.41) | MEN1KMT2ACCNE2CDK4CCND1 | |
| SCHEMBL18040350 | 0.95 | CYP2D6 (0.41) | MEN1KMT2ACCNE2CDK4CCND1 | |
| SCHEMBL17923208 | 0.95 | CYP2D6 (0.41) | MEN1KMT2ACCNE2CDK4CCND1 | |
| SCHEMBL29182441 | 0.94 | CHRM2 (0.43) | MEN1KMT2ACCNE2CDK4CCND1 | |
| SCHEMBL29182460 | 0.94 | CHRM2 (0.43) | MEN1KMT2ACCNE2CDK4CCND1 | |
| SCHEMBL29182446 | 0.94 | CHRM2 (0.43) | MEN1KMT2ACCNE2CDK4CCND1 | |
| SCHEMBL25338317 | 0.90 | MEN1 (0.38) | MEN1KMT2ACCNE2CDK4CCND1 | |
| SCHEMBL20595815 | 0.90 | MEN1 (0.38) | MEN1KMT2ACCNE2CDK4CCND1 | |
| SCHEMBL29182442 | 0.90 | MEN1 (0.38) | MEN1KMT2ACCNE2CDK4CCND1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12583883-B2 | Asymmetric auxiliary group | WAVE LIFE SCIENCES LTD. (SG) | 2026-03-24 | — | — | US | disclosed |
| CN-107011400-A | Asymmetric auxiliary group | 日本波涛生命科学公司 | 2017-08-04 | — | — | CN | disclosed |
| US-5527923-A | Process for preparing enantiomerically pure diarylprolinols | BOEHRINGER INGELHEIM KG (DE) | 1996-06-18 | — | — | US | disclosed |
| EP-0682013-A1 | Novel process for the preparation of enantiomerically pure diarylprolinols | BOEHRINGER INGELHEIM KG (DE) | 1995-11-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12583883-B2 | Asymmetric auxiliary group | AGL, RNMT, NSUN2 | MEN1 2629/4885KMT2A 2075/4885CCNE2 1414/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.